Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

164.92
+1.741.07%
Post-market: 164.920.00000.00%19:57 EDT
Volume:1.19M
Turnover:196.27M
Market Cap:22.13B
PE:-47.07
High:167.90
Open:164.54
Low:161.22
Close:163.18
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.58
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-99.30
PE(LYR):-49.67

Loading ...

Stock Track | Guardant Health Soars 5.67% in 24 Hours on Q2 Revenue Beat and Upbeat Full-Year Guidance

Stock Track
·
Jul 31

Movement Alert|Guardant Health Inc. Rises 6.33% in After-Hours Trading, Q2 Revenue Beats Expectations and Full-Year Guidance Raised

Market Focus
·
Jul 31

Guardant Health files automatic mixed securities shelf

TIPRANKS
·
Jul 31

Guardant Health Inc Files for Mixed Shelf Offering; Size not Disclosed- SEC Filing

THOMSON REUTERS
·
Jul 31

Stock Track | Guardant Health Soars 7.65% in After-Hours Trading on Q2 Revenue Beat and Raised 2026 Guidance

Stock Track
·
Jul 31

Guardant Health Q2 Adjusted Loss Narrows, Revenue Rises

MT Newswires Live
·
Jul 31

GUIDANCE: (GH) Guardant Health Now Expects Full Year 2026 Revenue Range $1.34B - $1.36B, vs. FactSet Est of $1.31B

MT Newswires Live
·
Jul 31

Guardant Health Q2 Adj. EPS $(0.42) Misses $(0.41) Estimate, Sales $334.978M Beat $314.226M Estimate

Benzinga Earnings
·
Jul 31

Guardant Health Q2 Adjusted EPS USD -0.42 Vs. IBES Estimate USD -0.41

Reuters
·
Jul 31

Guardant Health - Sees 2026 Free Cash Flow Burn $195-$205 Mln

THOMSON REUTERS
·
Jul 31

Movement Alert|Guardant Health Inc. Rises 5.02% in Regular Trading, Bristol-Myers Squibb Cancer Drug Beat Lifts Oncology Diagnostics Sector

Market Focus
·
Jul 31

Guardant Health to Present at Canaccord Genuity Growth Conference Fireside Chat

Reuters
·
Jul 30

GH Research Initiated at Overweight by Wells Fargo

Dow Jones
·
Jul 27

GH Research initiated with an Overweight at Wells Fargo

TIPRANKS
·
Jul 27

Earning Preview: Guardant Health Inc. this quarter’s revenue is expected to increase by 48.77%, and institutional views are bullish

Earnings Agent
·
Jul 24

Movement Alert|Guardant Health Falls 5.06% in Regular Trading, Trading at $148.395

Market Focus
·
Jul 20

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,941.64

Reuters
·
Jul 17

Movement Alert|Guardant Health Falls 5.02% in Regular Trading, Trading at $154.86

Market Focus
·
Jul 17

Guardant Health is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 16

Guardant Health price target raised to $190 from $160 at Guggenheim

TIPRANKS
·
Jul 16